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Abstract
Chronic viral infections can persist in an infected person for decades. From the perspective of the virus, a
single infection can span thousands of generations, leading to a highly diverse population of viruses with
its own complex evolutionary history. We propose a mathematical framework for understanding how the
emergence of new viral strains and phenotype within infected persons affects the population-level control
of those infections by both non-curative treatment and chemo-prophylactic measures. We consider the
within-host emergence of new strains that lack phenotype novelty and also the evolution of variability
in contagiousness, resistance to therapy, and efficacy of prophylaxis. Our framework balances the need
for verisimilitude with our desire to retain a model that can be approached analytically. We show how
to compute the population-level basic reproduction number accounting for the within-host evolutionary
process where new phenotypes emerge and are lost in infected persons, which we also extend to include both
treatment and prophylactic control efforts. This allows us to make clear statements about both the global
and relative efficacy of different control efforts accounting for within-host phenotypic evolution. Finally, we
give expressions for the endemic equilibrium of these models for certain constrained versions of the within-
host evolutionary model providing a potential method for estimating within-host evolutionary parameters
from population-level genetic sequence data.
Keywords: Multi-strain infectious diseases, Mathematical modeling, Basic reproduction number,
Sensitivity analysis
1. Introduction
Pathogens that lead to persistent chronic infection in people must mitigate both the innate and adaptive
immune systems. Strategies for evading the innate immune system are complex including direct subversion
of host signaling pathways [12]. Pathogens such as HIV avoid the adaptive immune system by simply
evolving new phenotypes faster than the host immune system can adapt leading to a rapid co-evolutionary
race. Because HIV has a short generation time and generates a massive number of new viral particles
each day [16], this evolutionary race creates a large potential for the emergence of new viral strains and
phenotypes. This rapid evolutionary process is one of the many reasons that HIV is exceedingly difficult
to treat. Mutations that evolve in a single host are also known to be transmitted. In 2014-2016, 6 out
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of 11 countries looking for the presence of pre-treatment drug resistance (i.e. presence of a drug resistant
phenotype in persons unexposed to the drug) reported greater than 10% of new infections were resistant to
one or more non-nucleoside reverse-transcriptase inhibitor, which is related to both treatment failure and
death [15]. The rapid emergence of new viral phenotypes within infected persons is not just a clinical problem,
it is an epidemiological problem. Chemo-prophylactic measures that focus on protecting uninfected persons
using similar drugs to those used for treating infected persons are not immune to evolutionary derailment.
In King Country, Washington, 0.5% people living with HIV were found to have resistance mutations to the
drugs used for prophylaxis [15]. However, with the emergence of chemo- and bio-prophylactic agents (i.e.
anti-HIV antibodies for prevention), we must consider the possibility that population-level administration
of these agents can shift the ever evolving landscape of chronic viral infections.
This paper is motivated by a need for mathematical models that integrate within-host genetic diversity
and phenotypic evolution with epidemiological dynamics and consider the effects of joint therapeutic and
prophylactic controls. We also attempted to balance the complexity of the model to be usable as a data
analysis tool with the desire to understand the mathematical and statistical properties of the model using
analytical methods. Our model accounts for within-host evolution among multiple phenotypes characterized
by variable contagiousness, resistance to prophylactic measures, and resistance to therapeutic measures.
Our framework allows for new phenotypes to emerge in chronic infection that can be both transmitted and
possibly lost in later hosts. We consider both the epidemiological and evolutionary effects of both therapy
for infected persons and chemo-prophylaxis-type measures for uninfected persons.
There has been a number of results devoted to the analysis of different aspects of the evolutionary and
epidemiological dynamics of a multi-strain pathogen. While there is a wide spectrum of different models
covering different aspects of virus/immune system evolution and their interaction, most developed models
are too complex to be analyzed analytically thus, their analysis restricts to carrying out and analyzing the
results of numerical simulations. Our model is related to the approach to Lythgoe et al. [11] that considers
the possibility of a person infected with virus of type i can transmit a virus of type j at a time-dependent
rate βij(t). While this approach presents a detailed model of the within-host viral evolution, it requires a
substantial amount of data which is not readily available: virus reproduction, mutation and death rates.
Furthermore, since we need to take into account the duration of the infection at the time when transmission
occurs, the system dynamics is governed by integro-differential equations which are difficult to deal with. On
the other hand, such a detailed approach turns out to be an overkill as the total pool of infected contain the
individuals at different stages of disease and hence, the transmission rates undergo a sort of averaging over
the whole set of infected. Therefore, we employ a simpler formalism in which we treat the virus evolutionary
dynamics in a more coarse grained fashion. This allows us to balance our mutual goals of a sufficiently
complex model that can still be aproached analytically.
Complex multi-strain models have been proposed for influenza [9, 14] and dengue [1] that focus on both
cross-reactivity among circulating strains and coinfection [18] rather than the emergence of new strains
within infected hosts. Much of this work of this work is often based on complex models that are intended to
explain specific biological phenomena that are too complex to be understood by applied analysis methods.
On the other hand, there has been a number of papers devoted to the analytic analysis of certain aspects of
multi-strain virus dynamics. However, most of the papers either deal with rather restricted setups or study
only certain aspects of the system dynamics. We mention stability analysis of within-host multi-strain virus
dynamics with mutations [3]; analysis of a multi-strain (actually two-strain) disease with environmental
transmission, no mutations [2]; bifurcation analysis of a number of (rather simple) multi-strain epidemio-
logical models without mutation [8].
Further information about different approaches to modeling the evolutionary and population-based dy-
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namics of multi-strain pathogens as well as the description of the problems that arise in this connection can
be found in [10, 21]
It should be noted that most research effort aimed at studying the dynamics of multi-strain viruses does
not take into account the possibility of within-host mutations and concentrate on modeling different immune
system responses in reaction to re-infection or co-infection. In contrast to that, we are more concerned with
the effect of mutations on both the within-host and population-level distribution of viral strains and on how
both the emergence and loss of phenotypes within infected persons alters the population-level control of
chronic viral infections.
2. Description of the models and their structural properties
2.1. A baseline model of a chronic multi-strain virus infection
In the baseline version of the model we consider the within-host evolution and transmission of distinct
strains that have the same phenotype. Most observed mutations at the nucleotide level will not alter a
pathogen’s phenotype, but they can be used in combination to discern unique lineages of transmission.
In order to account for virus variability, the whole set of viruses is divided into n groups (strains), Vi,
i = 1, . . . , n. An individual gets infected by a virus of particular type i. During the acute stage the patient’s
viral population consists of viruses of the same type, while during the chronic stage the original virus mutates
thus producing strains of all types. Therefore, we assume that each chronically infected individual’s viral
population contains viruses of all n types in the proportion that depends on the initial type of the virus.
To model the process of disease propagation we employ an SI model and assume that there are two stages
of the disease: the acute and the chronic one. Furthermore, we extend the set of state variables to include
the individuals enrolled into treatment. In doing so we assume that the treatment is completely efficient
and the patients are fully compliant with the treatment.
When writing the differential equations of the model we assume the inflow to be equal to the outflow
hence, the total population size remains constant. Therefore, we write the model equations for the fractions
of the respective cohorts in the total population. This implies, in particular, that the sum of all the states
is equal to 1. We have the following set of DEs (state variables and parameters defined in Table 1):
I˙Ai = φi(X)S − γIAi − µIAi
I˙Ci = γIAi − uTICi − µICi
T˙ = uT
n∑
i=1
ICi − µT
S˙ = µ−
n∑
i=1
φi(X)S − µS
(1)
where X = [IA1, . . . , IAn, IC1, . . . , ICn, T, S] is the (2n + 2)-dimensional state vector, i ranges from 1 to n,
and the respective forces of infection are defined as
φi(X) = βAIAi + βC
n∑
j=1
αijICj . (2)
In (2), αij ∈ [0, 1] denotes the average fraction of type i viruses in the viral population of an individual
initially infected by the type j virus. It should thus hold that
∑n
i=1 αij = 1 for all j = 1, . . . , n. Furthermore,
we assume that αii 6= 0 for all i = 1, . . . , n. This means that the viral population of an individual infected
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with the type i virus always contains a non-zero amount of the corresponding strain. Parameters βA and
βC are the transmissibility rates of acute and chronically infected individuals. In this simple setting we
assume that the probability that a susceptible individual contracts a disease depends only on the disease
stage of the infected contact, but not on the type of virus. That is to say, a susceptible can be equally well
infected by any virus. In the following, we will assume that βA and βC differ by a proportionality coefficient
ξ: βA = ξβC
1. With this, expression (2) turns into
φi(X) = βC
ξIAi + n∑
j=1
αijICj
 . (3)
2.2. A generalized model with differentially effective control, variable transmissibility and prophylaxis
We generalize the baseline model by allowing different strains to have different phenotypes by relaxing
the model assumptions along the following lines:
• The treatment program does not ensure complete suppression of viral replication. That is to say, the
treatment program fails with certain probability, which varies depending on the virus strain.
• Virus strains have different transmissibility.
• In addition to the treatment, we consider the effect of chemical or biological prophylaxis. While on
prophylaxis, an individual acquires protection against the virus, the extent of which depends on the
virus strain.
To account for different failure rates of treatment we divide the group of people on treatment into
n compartments Ti, where i corresponds to the virus strain. Furthermore, we add a cohort of people
receiving prophylaxis, denoted by P . While on prophylaxis, the individuals acquire variable protection
against different virus strains denoted by ψi ∈ [0, 1] with ψi = 1 corresponding to full protection. Thus we
have the following model:
I˙Ai = φi(X)S + (1− ψi)φi(X)P − γIAi − µIAi
I˙Ci = γIAi + ζiTi − uTICi − µICi
T˙i = uTICi − ζiTi − µTi
S˙ = µ− uPS −
n∑
i=1
φi(X)S + δP − µS
P˙ = uPS −
n∑
i=1
(1− ψi)φi(X)P − δP − µP
(4)
where ζi ≥ 0 is the failure rate associated with the ith control, δ is the inverse duration of prophylaxis,
and uT, resp., uP are the rates at which people are administered to either treatment or prophylaxis. To
account for variable transmissibility of different virus strains we define a set of transmissibility rates βAi and
βCi, i = 1, . . . , n. Similarly to the baseline case, the transmissibility rates for the corresponding acute and
chronic stages are assumed to be proportional, i.e., βAi = ξβCi. The forces of infection φi(X) are defined as
φi(X) = βCi
ξIAi + n∑
j=1
αijICj
 . (5)
1We shall still occasionally write βA if it makes the notation more straightforward.
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Note that setting either ζi = 0 or ψi = 0 or βCi = βC for all i = 1, . . . , n, we obtain different variations of
the baseline model.
Notation. We let 0, 1, and E denote the matrices of zeros, ones, and the identity matrix2. The sizes of the
respective matrices are indicated as subscripts. A single subscript, e.g., as in En, denotes a square [n× n]
matrix of respective type. Furthermore, IA and IC denote the column vectors of respective variables and
A denotes the matrix of α’s:
IA =

IA1
...
IAn
 , IC =

IC1
...
ICn
 , and A =

α11 . . . α1n
...
. . .
...
αn1 . . . αnn
 .
Note that A is a non-negative, column stochastic matrix, i.e., all its columns sum to 1.
All parameters and variables used in the model are listed in Table 1. Note that all quantities used are
assumed to take on non-negative values and the index i always runs from 1 to n.
Table 1: Model parameters
Variable Range Description
IAi [0, 1] Fraction of acutely infected individuals infected by the virus of type i.
ICi [0, 1] Fraction of chronically infected individuals infected by the virus of type i.
S [0, 1] Fraction of susceptible individuals
T [0, 1] Fraction of patients involved in treatment
Ti [0, 1] Fraction of patients infected by the virus of type i that are involved in treatment
Parameter Range Description
γ Inverse duration of the acute phase
uT Fraction of chronically infected that are enrolled into treatment (controlled
parameter)
uP Fraction of chronically infected that are enrolled into prophylaxis (controlled
parameter)
µ Mortality rate
αij [0,1] Fraction of type i viruses in the viral population of an individual initially
infected by the type j virus.
βA, βC Transmissibility rates of acute and chronically infected individuals.
ξ Proportionality coefficient of the transmissibility in acute and chronic stages
ζi Failure rate of treatment for individuals infected by the virus of type i
δ Failure rate of prophylaxis
2.3. Structural analysis
In this subsection we consider only the baseline model (1) since the extended model has the same
properties and can be readily analyzed along the same lines.
2The use of notation E instead of I for the identity matrix is common in German and Russian mathematical texts (Germ.,
Einheitsmatrix). Here we use it to avoid confusing the notation I with the letter I used for infected compartments.
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Non-negativity of the solutions. The equations (1) can be written as
d
dt

IA
IC
T
S
 =

βC [ξ IA + A IC]S − (γ + µ) IA
γ IA − µ IC
−µT
µ− βC1[1×n] [ξ IA + A IC]S − µS
+

0[n×1]
− IC
1[1×n] IC
0
uT = Ψ(X) + Ψu(X)uT. (6)
The vector-valued functions Ψ(X) and Ψu(X) are essentially non-negative, i.e., for all j = 1, . . . ,m, m =
2n+ 2, it holds that Ψj(X˜) ≥ 0 (resp., Ψuj (X˜) ≥ 0) for any X˜ ∈ Rm≥0 such that X˜j = 0 (see [4] for details).
This implies that solutions of (1) are non-negative. That is to say, for any non-negative initial condition
X(0) = X0 ∈ Rm≥0 and any non-negative control uT the solution of (1) belongs to Rm≥0 for all t ≥ 0.
Boundedness of solutions. Observe that the m-simplex ∆m, formed as the convex hull of m unit vectors ej ,
j = 1, . . . ,m, is invariant with respect to (1):
X(0) ∈ ∆m ⇒ X(t) ∈ ∆m,
where ∆m = {X ∈ Rm≥0|
∑m
j=1Xj = 1}. This result follows immediately from the fact that the states Xi
represent the fractions of the respective groups within the total population and hence sum to 1.
3. Local analysis at a disease-free equilibrium
Below, we will compute the basic reproduction number for two considered models and present a number
of related results. To distinguish between the basic reproduction numbers related to different models we
will add a superscript denoting the particular model: α for the baseline model (1) and β for the extended
model (4).
3.1. Basic reproduction number for the baseline model
The system (1) has a unique disease-free equilibrium (DFE) XDFE = [0, . . . , 0, 1]. To analyze the stability
property of the system (1) at the DFE we compute the controlled basic reproduction number R0 using the
classical next-generation method [17] (see [5] for an extension of the method that takes into account the
action of a control).
Theorem 3.1. For any choice of parameters αij ≥ 0 such that
∑
i αij = 1 and αii 6= 0 for all i, j = 1, . . . , n,
the controlled basic reproduction number of the system (1) is given by
Rα0 (uT) = βC
ξ(uT + µ) + γ
(γ + µ)(uT + µ)
=
ξβC
γ + µ
+
βCγ
(γ + µ)(uT + µ)
. (7)
Proof. See Appendix B.
Note that the αij values do not affect the basic reproduction number, which makes sense in this context as
mutation from one strain into another does not imply any change in a relevant phenotype such as conta-
giousness or resistance to therapy. In this context, a different strain simply carries a distinct mutation (or
pattern of mutations) that makes it identifiable from other strains. However, understanding the distribution
of strains with the same phenotype is an important aspect of molecular epidemiology, which is dependent
on the specific αij values. This relationship between within-host mutations and endemic equilibrium of
infection types is discussed below.
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Sensitivity analysis. When devising an intervention strategy, the main question to be answered is whether
the proposed treatment or prophylaxis scheme is capable of eliminating the infection, i.e., driving the basic
reproduction number below 1. To address this issue we introduce the sensitivity parameter(s) R1 that
quantify the efficiency of sufficiently small controls in reducing the value of R0, [5]. In particular, the
controlled basic reproduction number Rα0 (uT) is expanded as
Rα0 (uT) = R
α
0 +R
α
1 uT +O(u2T), (8)
where Rα0 = R
α
0 (0) = βC
γ+ξµ
µ(γ+µ) and R
α
1 = − βCγµ2(γ+µ) . Before proceeding with the further analysis, we define
the notion of efficiency of a control.
Definition 3.1. Let the uncontrolled basic reproduction number be larger than 1, i.e., R0(0) > 1. A control
u is said to be
1. locally efficient if the respective sensitivity parameter is negative, i.e., Ru1 < 0;
2. (globally) efficient if there exists a non-negative value u∗ such that R0(u∗) = 1.
Furthermore, we say that a control is unconditionally locally (globally) efficient if 1. (2.) holds for all
admissible values of parameters. Otherwise the control is said to be conditionally efficient.
We can immediately observe that uT is unconditionally locally efficient. However, an unconditionally
locally efficient control may fail to reach the stated goal of eliminating the infection, i.e., reducing R0 below
1. The following result illustrates that.
Lemma 3.2. The control uT is efficient if βC satisfies
ξβC < γ + µ. (9)
Proof. This result can be easily checked by observing the expression for Rα(uT) in (7) and noting that
the second summand vanishes as uT tends to infinity.
Remark 3.1. Note that the condition (9) can be alternatively rewritten as βAθA < 1, where θA = 1/(γ+µ)
denotes the average duration of the acute stage.
The result of Lemma 3.2 implies that the control uT is only conditionally globally efficient. That is, it
can be used to completely eliminate the infection only if the transmissibility βC satisfies (9).
3.2. Basic reproduction number for the extended model
In contrast to the baseline case, the disease free equilibrium for the modified model (4) is shifted due to
the action of the control uP. So, we have
XDFE = [01×n, 01×n, 01×n, PDFE , SDFE ], (10)
where SDFE(uP) =
δ+µ
δ+µ+uP
and PDFE(uP) = 1 − SDFE(uP) = uPδ+µ+uP . Local stability of the DFE
(10) is determined by Rβ0 (uT, uP). Before we proceed with the analysis, we note that the results to fol-
low will be formulated using matrix notation. In particular, we will write BC = diag(βC1, . . . , βCn),
Ψ = diag(ψ1, . . . , ψn), and Z = diag(ζ1, . . . , ζn) to denote the diagonal matrices of transmissibility rates,
protection factors and treatment failure rates.
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Theorem 3.3. The controlled basic reproduction number of the system (4) is given by
Rβ0 (uT, uP) =
β¯C(γ + ξµ)
(γ + µ)µ
ρ (Q(uP)N(uT)) , (11)
where β¯C = maxi βCi, B¯C = β¯
−1
C BC, Q(uP) = B¯C [ En − PDFE(uP)Ψ], N(uT) = 1γ+ξµ [ξµEn + γA∆(uT)],
and ∆(uT) = ( Z + (µ+ uT) En)
−1( Z + µEn).
Proof. See Appendix B.
Note that the basic reproduction number of the extended system is a product of two terms: the first one
closely resembles Rα0 as in (8), while the second term is a spectral radius of the product of two matrices,
where the first one depends only on uP and the second one depends only on uT.
Before we proceed with the analysis, we formulate an important result on stochastic matrices.
Lemma 3.4. Let Σ be a non-negative, column stochastic matrix. Then for any α ∈ [0, 1], the convex
combination Σα = αE + (1 − α)Σ is a column stochastic matrix as well. Furthermore, the left and right
dominant eigenvectors of Σ coincide with those of Σα.
The above result implies that N(0) = 1γ+ξµ [ξµEn + γA] is a column stochastic matrix, whose left and
right dominant vectors coincide with those of A. We will thus write N(0) = A¯.
Sensitivity analysis. We begin this paragraph by writing down an expansion of Rβ0 (uT, uP).
Theorem 3.5. Let A be irreducible and let w0 and v0 be the right and the left dominant eigenvectors of
Q(0)N(0) = B¯C A¯, corresponding to ρ
(
B¯C A¯
)
and normalized such that w>0 v0 = 1. The controlled basic
reproduction number Rβ0 (uT, uP) can be written as
Rβ0 (uT, uP) = R
β
0 +R
β
1,TuT +R
β
1,PuP +O(‖(uT, uP)‖2), (12)
where Rβ0 =
β¯C(γ+ξµ)
(γ+µ)µ ρ
(
B¯C A¯
)
, Rβ1,T = −w>0
[
Rβ0 En − ξ(γ+µ) BC
]
( Z+µEn)
−1v0, and R
β
1,P = −Rβ0 1(δ+µ)w>0 Ψv0.
Proof. See Appendix B.
This result has a number of important consequences as formulated below. We first consider a slightly
simplified setup. Let there be no variability in transmission rates, i.e., BC = βC En. Then the vectors w0
and v0 coincide with those of A. Furthermore, we have w0 = 1[n×1]. The respective coefficients turn into
Rβ0 = R
α
0 , R
β
1,T = −Rβ0 γγ+ξµw>0 ( Z + µEn)−1v0, and Rβ1,P = −Rβ0 1(δ+µ)w>0 Ψv0. That is, we can write
Rβ0 (uT, uP) = R
β
0
(
1− γ
γ + ξµ
w>0 ( Z + µEn)
−1v0 · uT − 1
(δ + µ)
w>0 Ψv0 · uP
)
+O(‖(uT, uP)‖2).
Obviously, both controls are unconditionally locally efficient. We can also observe that the control uT is
locally more efficient than uP if it holds that
γ
γ + ξµ
w>0 ( Z + µEn)
−1v0 >
1
(δ + µ)
w>0 Ψv0. (13)
Obviously, we have that uP is locally more efficient if the opposite holds true. The inequality (13) can be
interpreted as follows. Note that τi = 1/(ζi + µ) and pi = 1/(δ+ µ) are the average duration of being either
on treatment or on prophylaxis and recall that w>0 = [1, . . . , 1]. Then we can write (13) as∑
i
γ
γ + ξµ
τiv0i >
∑
i
ψipiv0i.
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Here, the factor γ/(γ + ξµ) is interpreted as the degree of protection given by the treatment. Note that
this number decreases with increasing ξ, i.e., when the acute stage is much more contagious compared to
the chronic stage. If ξ = 1, the fraction γ/(γ + µ) merely corresponds to the fraction of people that survive
to the chronic stage. Note that this interpretation has to do with the fact that we assume the acute stage
is short enough that people will not start treatment conditional on being in the chronic stage of infection
and therefore the acute to chronic stage contagiousness of infection is a major determinant of the efficacy
of therapy as a population-level control. This assumption is reasonable for diseases like HIV, but may need
to be revisited for application to other diseases. Next, we note that the components of the vector v0 are
proportional to the stationary distribution of different strains of the virus in the baseline model (see Sec.
4 for more details on that). Thus, we can interpret the sensitivity parameters Rβ1,T and R
β
1,P as a sum of
products average duration of the medical intervention × protection conferred by the intervention taken with
the weights corresponding to the stationary distribution of the virus strains.
Following the same line, one can attempt to compare the efficiency of two controls in the general case.
To start with, we write (12) as
Rβ0 (uT, uP) = R
β
0
(
1− w>0
[
En − ξ
(γ + µ)Rβ0
BC
]
( Z + µEn)
−1v0uT − 1
(δ + µ)
w>0 Ψv0uP
)
+O(‖(uT, uP)‖2)
As above, we say that uT is locally more efficient than uP if
∑
i
[
1− βAiθA
Rβ0
]
τiw0iv0i >
∑
i
ψipiw0iv0i. (14)
Similarly to the previous case, we interpret the expression in front of τi as the degree of protection given
by the treatment to those infected with the i-type virus. Note that a sufficient condition for this expression
to be positive is βAiθA < 1. In contrast to the previous case, the components w0iv0i do not have that clear
interpretation. However, their behavior is pretty close to that of v0i as the numerical simulation presented
in Fig. 2 illustrates.
Finally, we observe that for sufficiently large controls uT and uP we have
lim
uT→∞
uP→∞
Rβ0 (uT, uP) =
ξ
(γ + µ)
ρ ( BC [ En −Ψ]) = ξ
(γ + µ)
max
i
(βC,i(1− ψi)),
which yields the result that agrees with the result of Lemma 3.2.
Lemma 3.6. The controls uT and uP are jointly globally efficient if
ξmax
i
(βC,i(1− ψi)) < γ + µ.
4. Endemic equilibrium
In contrast to the unique disease-free equilibrium, there can be one, many (a continuum), and no endemic
equilibria at all. Which case realizes in our system depends on the value of the basic reproduction number and
on the structure of the matrix A as will be shown below. For the general case, the endemic equilibrium can
be computed using a rather involved semi-analytic procedure and offers a little insight into the structure of
the respective equilibrium. Therefore, we restrict ourselves to the baseline model and a particular extension
thereof. The general model is considered in Section 5 that is devoted to the numerical simulations.
9
4.1. A baseline model
We begin by stating a general result on the endemic equilibrium.
Theorem 4.1. Let A be an irreducible non-negative column stochastic matrix such that all diagonal elements
are non-zero. Then the endemic equilibrium for the system (1) exists and is unique if R0 > 1. Let,
furthermore, v> = [v1, . . . , vn] be the right normalized eigenvector of A corresponding to the dominant
eigenvalue of A and satisfying
∑n
i=1 vi = 1. The components of the endemic equilibrium state are given by
I∗Ai =
µ
(γ + µ)
(
1− 1
R0
)
vi, I
∗
Ci =
γµ
(γ + µ)(uT + µ)
(
1− 1
R0
)
vi,
T ∗ =
γu
(γ + µ)(uT + µ)
(
1− 1
R0
)
, S∗ =
1
R0
.
(15)
Proof. See Appendix B.
Note that the only additional property of the matrix A that is involved in this theorem is that A is
irreducible. For the definition of irreducibility and further details see Appendix A.
The obtained result can be used to compute a number of derived quantities. For instance, we have that
the total prevalence at the endemic equilibrium is equal to
Π = 1− S∗ = R0 − 1
R0
and the the ratio of transmissions through acutely infected to the transmission through chronically infected
is given by
rAC =
ξβC
∑n
i=1 IA,i
βC
∑n
i=1 IC,i
=
ξβCiAΣ
βCiCΣ
=
ξβC(uT + µ)
βCγ
. (16)
Using the statistical estimations of these two parameters one can recover ξ and βC.
Before we proceed to the next result we recall that αij can be interpreted as the probability of catching
a virus of type i through the contact with an individual initially infected by the virus of type j. So, we can
make the following observation.
Lemma 4.2. At the endemic equilibrium, the probability of encountering a chronically infected in the ith
category is equal to the probability of catching the type i virus through the contact with a randomly chosen
chronically infected individual:
I∗Ci =
n∑
j=1
αijI
∗
Cj .
Proof. Using the expression for I∗Ci, we can write
n∑
j=1
αijI
∗
Cj =
γµ
(γ + µ)(uT + µ)
(
1− 1
R0
) n∑
j=1
αijvj .
However, since v is the stationary eigenvector of A, it holds that
∑n
j=1 αijvj = vi, whence the result
follows.
If the matrix A is reducible, the results of Theorem 4.1 do not apply any longer. However, we can
formulate a weaker version of the theorem. First, we note that a reducible matrix can be transformed to
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the normal form by means of a properly chosen permutation matrix:
A˜ = PAP> =

A˜1 ∗ . . . ∗
0 A˜2 . . . ∗
...
. . . ∗
0 0 . . . A˜k
 , (17)
where Ai, i = 1, . . . , k are irreducible matrices and asterisks denote arbitrary non-negative matrices.
Theorem 4.3. Let A be a reducible non-negative matrix with non-zero diagonal elements such that it
can be transformed into the normal form (17) by an appropriate simultaneous permutation of rows and
columns. Then A has at most k unit eigenvalues. Furthermore, let v = {v1, . . . , vq} be the set of normalized
eigenvectors corresponding to the unit eigenvalues, q ≤ k. Then the set of endemic equilibria is defined as
follows:
I∗Ai =
µ
(γ + µ)
(
1− 1
R0
)
v¯i, I
∗
Ci =
γµ
(γ + µ)(uT + µ)
(
1− 1
R0
)
v¯i,
T ∗ =
γu
(γ + µ)(uT + µ)
(
1− 1
R0
)
, S∗ =
1
R0
,
(18)
where the vector v¯ belongs to the linear hull of vectors from v: v¯ ∈ Span(v).
Theorem 4.3 implies that the set of endemic equilibria can form a linear subspace of the system’s state
space. The case when the matrix A is reducible corresponds to the situation when there are some particular
groups of virus strains, say, two groups G1 and G2. Reducibility implies that the mutations between these
groups are either not possible at all, G1 = G2 or possible only in one direction, G1 ← G2, but G1 9 G2 (or
vice versa). Such a setup allows for considering directed patterns of viral evolution. However, this question
is beyond the scope of this paper and will be addressed in our future work.
Structure of the matrix A: uniform within host mutations. An important observation that follows from the
preceding analysis is that one cannot unambiguously determine all n2 parameters αij from the observations
made at the endemic equilibrium. The reason for that is that the equilibrium values depend on the n
components of the vector v (see (23)) of which only n−1 values are independent. We thus restrict ourselves
to considering one particular structure of the matrix A that can be formulated in terms of only n parameters.
More complex structures are possible and can be treated using the same results. In particular, Theorem 5.1
offers a convenient tool for computing the respective dominant eigenvector.
Assume that during the chronic infection stage the viral population of the individual, initially infected
with the type i virus contains the fraction αi of the original virus while the remaining strains of the virus
are distributed uniformly. This means that the matrix A has the following form:
A =

α1
1−α2
n−1 . . .
1−αn
n−1
1−α1
n−1 α2
1−αn
n−1
...
...
. . .
...
1−α1
n−1
1−α2
n−1 . . . αn
 . (19)
The matrix (19) is positive hence, the Perron-Frobenius theorem applies. There is a unique dominant
eigenvalue that is equal to 1, and the components of the dominant eigenvector have the following form:
vi =
∏
j 6=i(1− αj)∑n
i=1
∏
j 6=i(1− αj)
.
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The respective expressions for the system states at endemic equilibrium are pretty bulky. However, we can
compute the relative ratios of infected in different groups, which turn out to have a simple form:
rij =
IAi + ICi
IAj + ICj
=
vi
vj
=
1− αj
1− αi .
Note that the condition
∑
i vi = 1 implies that there are only (n − 1) independent equations. Thus, one
parameter αi can be set to an arbitrary value within the range [0, 1]. Let, for instance, αn be used as a free
parameter. In this case, all remaining probabilities can be expressed in terms of αn and vi:
aj = 1− (1− αn)vn
vj
, j = 1, . . . , n− 1.
In the following we will consider a slightly more realistic scenario in which all viruses are ordered according
to their genetic similarity and any virus can mutate only to its “neighbors”. The respective matrix A has
the following form:
A =

α1
1−α2
2 . . . 0
1− α1 α2 0
0 1−α22 . . . 0
...
...
. . .
...
0 0 . . . αn
 . (20)
Quite remarkably, the respective expressions do not change that much compared to the previous case. Setting
vi and assuming that αn can be freely chosen we get
α1 = 1− (1− αn)vn
v1
, αj = 1− 2(1− αn)vn
vj
, j = 2, . . . , n− 1.
4.2. Variable transmissibility
In this subsection we consider an extension of the baseline model in which different strains are assumed
to have different transmissibility rates. This implies that we consider the model (4) with uP = 0 and ζi = 0.
The respective set of DEs is written (in vector notation) as
I˙A = BC (ξIA +AIC)S − γIA − µIA
I˙C = γIA − uT IC − µIC
T˙ = uT
∑
IC − µT
S˙ = µ−
∑
BC (ξIA +AIC)S − µS.
(21)
For this case, the results of Theorems 3.3 and 4.1 can be restated as follows:
Theorem 4.4. The basic reproduction number Rβ0 (uT) for the system (21) is given by
Rβ0 (uT) = R
β
0 (uT, 0) =
β¯C(ξ(µ+ uT) + γ)
(γ + µ)(µ+ uT)
ρ
(
B¯CA¯
)
, (22)
where A¯ = 1ξ(µ+uT)+γ [ξ(µ+ uT) En + γA]. Let, furthermore, A be an irreducible non-negative column
stochastic matrix such that all diagonal elements are non-zero. Let, furthermore, v> = [v1, . . . , vn] be the
right normalized dominant eigenvector of B¯C A¯ satisfying
∑n
i=1 vi = 1. Then the endemic equilibrium exists
and unique if R0(uT) > 1 and the respective components of the endemic equilibrium state are given by
I∗Ai =
µ
(γ + µ)
(1− S∗) vi, I∗Ci =
γµ
(γ + µ)(uT + µ)
(1− S∗) vi,
T ∗ =
γu
(γ + µ)(uT + µ)
(1− S∗) , S∗ = 1
R0(uT)
.
(23)
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Proof. The expression for R0(uT) is obtained from (11) after some algebraic manipulations. The rest of
the proof closely follows the proof of Thm. 4.1.
We note that A¯ is a stochastic matrix and has the same right and left dominant eigenvectors as A due to
Lemma 3.4. The product B¯CA¯ corresponds to multiplying the rows of A¯ with the respective β¯Ci. For this
expression one cannot find the dominant eigenvector analytically, so we consider some numerical examples
to illustrate the influence of variable transmissibility on the distribution of different virus strains.
Example 4.1. Consider a model with 4 virus strains. We take the following values of the parameters:
µ = 0.025, γ = 3 (i.e., the acute phase takes about 4 months); ξ = 5 (during the acute phase an individual
is 5 times more contagious as in the chronic one); uT = 0.4 (it takes 2.5 years on average till the treatment
begins). The transmissibility rate βC was chosen such that R0(uT = 0.4) ≈ 1.2: βC = 0.25. The matrix A is
assumed to have the form (20) and the probabilities αi are chosen in the way that the endemic distribution
of the different virus strains for the baseline model satisfies vj/vj+1 = 3. That is, the endemic frequencies
are [v1, v2, v3, v4] = [0.675, 0.225, 0.075, 0.025]. Finally, we set α4 = 0.25. The remaining probabilities are
computed to be α1 ≈ 0.97, α2 ≈ 0.83, and α3 = 0.5.
To see how varying transmissibility influences the endemic distribution we fix the transmissibilities of
the first 3 strains to be equal to βC, while the transmissibility of the fourth strain is βC4 = aβC, where a
changes from 0.7 to 2. The resulting endemic frequencies are shown in Fig. 1a. Note that at a = 1 the
endemic distribution coincides with the baseline one.
a) b)
Figure 1: The endemic distribution of acutely infected (IAi) for different values of the transmissibility rate of the 4th strain,
parametrized with a: βC,4 = aβC. The values at a = 1 correspond to the baseline case (all transmissibility rates are equal).
Subfigures a) and b) correspond to different values of mutation probabilities αi.
To make a comparison, we consider a different set of parameters αi. In this case, we assume that these
parameters are chosen such that the endemic distribution in the baseline case satisfies vi/vi+1 = 7. The
respective values are α1 = 0.9985, α2 = 0.9796, α3 = 0.8571 and α4 = 0.25 (the last parameter was chosen
to be equal to α4 in the previous case). The trajectories of the endemic frequencies are shown in Fig. 1b. It
is interesting to observe that variation in transmissibility of one strain leads to substantial variation in the
frequencies of the other strains as facilitated by within-host mutation.
For both cases, Fig. 2 illustrates the dependence of the products w0iv0i on the parameter α. One can
observe that the behavior of the respective terms (that enter the expression for the the sensitivity terms
Rβ1,T and R
β
1,P ) closely follows that of v0i.
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a) b)
Figure 2: The change of the weights w0iv0i that enter the sensitivity terms R
β
1,T and R
β
1,P with the parameter a.
5. Numerical simulation for different scenarios
As for the numerical simulation we consider the following values: µ = 0.025, γ = 3, ξ = 5, uT = 0.4,
and βC = 0.25 (see Example 4.1 for an explanation). Similarly to the example, we considered the matrix A
as in (20) with α1 ≈ 0.97, α2 ≈ 0.83, and α3 = 0.5, and α4 = 0.25. At the initial time we set IA1 = 0.01,
S = 0.99, all remaining variables equal to 0.
Propylaxis. First, we simulate the baseline case with treatment and see that the endemic distribution agrees
with the assumed values (Fig. 3a). Next, we turn on prophylaxis at t = 50 and observe how it changes the
process (Fig. 3b). The respective control uP was set to 0.1 and the vector of protections against different
virus strains is assumed to be ψ = [0.9, 0.6, 0.3, 0.1]. We see that the endemic frequencies change in the
way that the frequency of the first strain decreases (since prophylaxis confers almost total protection against
this virus) and the frequency of the remaining strains increases. The (normalized) proportion of different
strains in the population of acutely infected is [0.616, 0.255, 0.096, 0.033]. For uP = 0.2 this effect becomes
even more pronounced. The respective frequencies are [0.547, 0.288, 0.121, 0.043]. On the other hand, as
uP grows, the total fraction of infected individuals decreases and asymptotically approaches zero.
Finally, we consider quite a radical setup in which prophylaxis confers total protection against two first
virus strains and no protection against the remaining two strains. For uP = 0.2, the respective frequencies
are [0.527, 0.277, 0.144, 0.053]. Comparing with the previous result we see that the difference is rather
minute. This implies that while imperfect prophylaxis leads to some increase in the frequencies of the
viruses that evade it, this increase is rather restricted. The main reason is that when prophylaxis covers a
small fraction of the population it does not create sufficient evolutionary pressure, while when it increases it
eventually contributes to the complete eradication of the disease. This result is potentially very encouraging
as new prevention methods for HIV based on administration of broadly neutralizing antibodies are predicted
to have highly differential levels of protection to diverse viral panels [19]. Although further work is needed
to explore the potential of selective prophylactic agents to cause strain-level selection in populations in the
context of within-host mutation.
Variable transmissibility. The next experiment is aimed at estimating the effect of variable transmissibility
of the final distribution of the virus strains. We assumed that the transmissibility of the fourth strain
is either 1.25 or 1.5 times larger than the transmissibility of other strains. The results turn out to be
quite impressive (see Fig. 4). While for the first case (Fig. 4a) the increase in transmissibility has led to a
substantial shift in the endemic frequencies: [0.361, 0.304, 0.214, 0.121], the second case is characterized by
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a) b)
Figure 3: Fractions of acutely infected (IAi) for the baseline model (a) and the baseline model with prophylaxis (b).
a) b)
Figure 4: Fractions of acutely infected (IAi) for the model with variable transmissibility.
a complete reshuffle of the strains (Fig. 4b). It should also be noted that an increase in the transmissibility
of one strain not only led to an increase of its endemic frequency, but also resulted in an increase in the
endemic frequencies of other strains! While the total fraction of acutely infected at the endemic equilibrium
is equal to
∑
i IAi = 7.72 · 10−4 in the first case, it increases to 13.0 · 10−4 in the second case – almost a
doubling! The respective endemic fractions are [0.103, 0.259, 0.35, 0.289].
Imperfect treatment. Now we consider the case when there is a chance of treatment failure. We set the
respective rates to be rather small: ζ = [0.025, 0.025, 0.05, 0.1] while keeping all remaining parameters
as in the baseline case. We also assume that there is no treatment. The result turns out to be quite
surprising: not only the endemic frequencies reshuffle, but also the total proportion of acutely infected
increases dramatically, see Fig. 5. The endemic frequencies are [0.055, 0.289, 0.467, 0.189] and the total
fraction of acutely infected is 44.0 · 10−4.
Conclusions
In this paper, we described two models of joint evolutionary and epidemiological dynamics of a viral
pathogen. While the first, baseline model did not take into account the phenotypic variability of the
virus, the extended model addressed the within-host evolution among multiple phenotypes characterized by
variable contagiousness, resistance to prophylactic measures, and resistance to therapeutic measures. We
presented an analytic expression for the controlled basic reproduction number for both cases and carried out
sensitivity analysis of the derived expression to the changes of the control actions. It turned out that the
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Figure 5: Fractions of acutely infected (IAi) for the model with imperfect treatment.
sensitivity coefficients RT1 and R
P
1 have a straightforward interpretation that can be used when assessing the
relative efficacy of the controls. Further, we characterized the endemic equilibria for the baseline model and
an extension thereof and shown that a sole assumption of variable transmissibility of different virus strains
can lead to wide variations in the endemic distribution of the respective strains. Finally, we carried out a
numerical analysis aimed at analyzing the effects of phenotypic diversity of virus strains on the population
level dynamics and distribution of different virus strains wihtin the population.
Appendix A. Necessary ingredients from matrix algebra
In this appendix, we present some facts about non-negative and stochastic matrices that will be used
in the sequel. The interested reader can find a thorough treatment of non-negative matrices, in particular
the Perron-Frobenius theory in [13, Ch. 8]. The theory of stochastic matrices within the context of Markov
chains is detailed in [7].
Non-negative matrices. A matrix M is said to be non-negative (positive), denoted by M  0 (M  0), if it
is element-wise non-negative (positive). The matrix M is said to be reducible if there exists a permutation
matrix P such that the conjugated matrix PMP> has a block upper-triangular form. Otherwise the matrix
M is said to be irreducible. The matrix M is primitive if it is non-negative and there exists k ∈ N such that
Mk  0. A non-negative irreducible matrix is primitive if at least one diagonal element is non-zero.
For irreducible non-negative matrices, there exists a real eigenvalue, called dominant that is equal to the
spectral radius of the matrix. The corresponding left and right dominant eigenvectors are positive. This
result follows from the celebrated Perron-Frobenius theorem [13, Ch. 8]. In a reducible case, the above
results should be substantially weakened to remain true. In particular, there can be multiple eigenvalues
corresponding to the spectral radius r and the respective eigenvectors are merely non-negative, rather
than positive. If a non-negative matrix M is reducible, it can be transformed to the normal form, which
corresponds to a block upper diagonal matrix such that the diagonal blocks are irreducible.
Stochastic matrices. A non-negative matrix Q is said to be column stochastic (row stochastic) is all its
columns (rows) sum to 1. The notions of (ir)reducibility, primitivity and the Perron-Frobenius theoren can
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be extended to stochastic matrices in a straightforward manner. Below we mention several properties that
are specific for stochastic matrices.
A stochastic matrix is typically used to describe the transition structure of a Markov chain. The spectral
radius of a stochastic matrix is equal to 1. The respective normalized right eigenvector v is called the
stationary distribution of the respective Markov chain, i.e., Qv = v. Here, normalization means that the
components of v must sum to 1. If the stochastic matrix is irreducible, then due to the Perron-Frobenius
theorem the stationary distribution is unique and component-wise positive. Finally, we present the result on
computing the stationary distribution of an irreducible stochastic matrix. This is a version of the Markov
chain tree theorem [6], formulated using the results from matrix theory (cf. [20]).
Theorem 5.1. Given an [n × n] irreducible column stochastic matrix Q , the ith element of the right
dominant eigenvector of Q is defined as the ith principal minor of the corresponding Laplacian Λ = Q−En:
wi = [Λ]i,i.
Proof. We have Qw = w, which is equivalent to (Q − En)w = Λw = 0. That is, w is the eigenvector
corresponding to the zero eigenvalue of Λ or, alternatively, w ∈ ker(Λ). By the Perron-Frobenius theorem,
the eigenspace associated with the dominant eigenvalue of Q, and hence, the kernel of Λ is one-dimensional.
By the definition of the adjugate, we have adj(Λ)Λ = Λ adj(Λ) = det(Λ)En = 0n. This means, in
particular, that the columns of adj(Λ) are linearly dependent and proportional to the stationary distribution
v.
By transposing the first expression we get Λ> adj(Λ)> = 0. The columns of Λ and hence, the rows of Λ>
sum to 0, which implies that the kernel of Λ> is a one-dimensional space spanned by 1[n×1]. This means that
each column of adj(Λ)> has the form coli
(
adj(Λ)>
)
= (−1)i+i[Λ]i,i · 1[n×1] = [Λ]i,i · 1[n×1]. Respectively,
each column of adj(Λ) has the form coli (adj(Λ)) =
(
[Λ]1,1, . . . , [Λ]n,n
)
. This concludes the proof.
Appendix B. Proofs
Proof (Theorem 3.1). The Jacobian matrix of (1) evaluated at the DFE has the form
DF
DX
∣∣∣∣
X=XDFE
=

(ξβC − (γ + µ)) En βC A 0[n×1] 0[n×1]
γ En −(u+ µ) En 0[n×1] 0[n×1]
0[1×n] u1[1×n] −µ 0
−ξβC1[1×n] −βC1[1×n] 0 −µ
 (24)
We observe that the stability of (24) is determined by the eigenvalues of its [2n × 2n] leading submatrix.
As a side remark, we mention that this implies that in our case the computation of R0 requires considering
both IA and IC as infected states (cf. the discussion at the end of Sec. 2 in [5]). Following the standard
procedure, we split the respective submatrix in two thus obtaining[
ξβC En βCA
0[n×n] 0[n×n]
]
+
[−(γ + µ) En 0[n×n]
γ En −(u+ µ) En
]
= F − V.
The basic reproductive number is defined as the spectral radius of the product FV −1, i.e., R0 = ρ(FV −1).
Using the standard result on the block matrix inversion we get
V −1 =
1
(γ + µ)(uT + µ)
[
(uT + µ) En 0
γ En (γ + µ) En
]
, (25)
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The product FV −1 is equal to
βC
(γ + µ)(uT + µ)
[
ξ(uT + µ) E + γA γA
0n 0n
]
and hence, R0 is found as the spectral radius of the [n×n] matrix (γ+µ)−1(uT+µ)−1βC [ξ(uT + µ) E + γA].
We use the well known facts that if λ is an eigenvalue of the matrix M , then aλ is an eigenvalue of the
matrix aM and k + λ is an eigenvalue of the matrix [kE + M ] for any α ∈ R, k ∈ R. This implies that
R0 =
βCγ
(γ+µ)(uT+µ)
(
ξ(uT+µ)
γ + ρ(A)
)
. Finally, since A is a column stochastic matrix, it holds that ρ(A) = 1
and hence, we obtain (7).
Proof (Theorem 3.3). The Jacobian matrix of (4) evaluated at the DFE has the form
DF
DX
∣∣∣∣
X=XDFE
=
ξΨ¯ BC − (γ + µ) En Ψ¯ BC A 0n 0[n×1] 0[n×1]
γ En −(uT + µ) En Z 0[n×1] 0[n×1]
0n uT En −µEn − Z 0[n×1] 0[n×1]
−ξ1[1×n] BCSDFE −1[1×n] BC ASDFE 0[1×n] −(µ+ uP) δ
−ξ1[1×n]( En −Ψ) BCSDFE −1[1×n]( En −Ψ) BC ASDFE 0[1×n] uP −(δ + µ)
 , (26)
where Ψ¯ = En − PDFEΨ.
The Jacobian (26) is a block lower-triangular matrix, whose bottom-right [2× 2] block is a negated M-
matrix and hence Hurwitz. Thus stability of the DFE is determined by the eigenvalues of the leading [3n×3n]
submatrix. As a side remark, we mention that this implies that the Ti compartments must be considered
as infected. That differs from what we observed in the baseline case and emphasizes the importance of the
right choice of the infected compartments (see the discussion at the end of Section 2 in [5]).
Following the standard procedure, we split the respective submatrix in two:ξΨ¯ BC Ψ¯ BC A 0n0n 0n 0n
0n 0n 0n
+
−(γ + µ) En 0n 0nγ En −(uT + µ) En Z
0n uT En −µEn − Z
 = F − V
A complete expression for the inverse of V is rather bulky. However, we note that since R0 is computed
as the spectral radius of FV −1, we need to compute only those blocks of the inverse that enter the leading
[n× n] submatrix of the product FV −1. So, we write
V −1 =
1
γ + µ
 En 0n 0nγµ ∆(uT) ∗ ∗
∗ ∗ ∗
 ,
where we used asterisks to denote the blocks that are not relevant to our problem. The diagonal matrix
∆(uT) is defined as
∆(uT) = ( Z + (µ+ uT) En)
−1( Z + µEn).
Finally we compute R0 to be
R0(uT, uP) =
1
(γ + µ)µ
ρ
(
ξµΨ¯ BC + γΨ¯ BC A∆(uT)
)
=
β¯C(γ + ξµ)
(γ + µ)µ
ρ
(
B¯CΨ¯
1
γ + ξµ
(ξµEn + γA∆(uT))
)
,
which is the equation (11). Note that B¯C and Ψ¯ are diagonal matrices and therefore commute.
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Proof (Theorem 3.5). The proof is similar to the proof of Theorem 3.43 in [5] and hence will only be
sketched. First, we note that Rβ0 = R
β
0 (0, 0) =
β¯C(γ+ξµ)
(γ+µ)µ ρ
(
B¯C A¯
)
. Computation of Rβ1,T and R
β
1,P coefficients
boils down to computing partial derivatives of Rβ0 (uT, uP) w.r.t. either uT or uP at uT = uP = 0. Using the
same approach as in [5], we get
Rβ1,T =
β¯C(γ + ξµ)
(γ + µ)µ
w>0 Q(0)R
′(0)v0,
Rβ1,P =
β¯C(γ + ξµ)
(γ + µ)µ
w>0 Q
′(0)R(0)v0.
Noting that Q(0) = B¯C, R(0) = A¯, Q
′(0) = dduPQ(uP)
∣∣∣∣
uP=0
= − 1δ+µ B¯CΨ and R′(0) = dduTR(uT)
∣∣∣∣
uT=0
=
− γγ+ξµ A( Z + µEn)−1 we obtain
Rβ1,T = −
β¯Cγ
(γ + µ)µ
w>0 B¯C A( Z + µEn)
−1v0, (27a)
Rβ1,P = −
β¯C(γ + ξµ)
(δ + µ)(γ + µ)µ
w>0 B¯CΨ A¯v0. (27b)
The expressions (27a) and (27b) can be further transformed using the fact that w0 and v0 are the left and
the right eigenvectors of B¯C A¯ corresponding to the spectral radius of this matrix and expressing ρ
(
B¯C A¯
)
through the basic reproduction number Rβ0 as shown below.
Rβ1,T = −
β¯C
(γ + µ)µ
w>0 B¯C[(γ + ξµ) A¯− ξµEn]( Z + µEn)−1v0
= − β¯C(γ + ξµ)
(γ + µ)µ
w>0 ρ( B¯C A¯)( Z + µEn)
−1v0 +
β¯Cξ
(γ + µ)
w>0 B¯C( Z + µEn)
−1v0
= −Rβ0w>0 ( Z+µEn)−1v0 +
β¯Cξ
(γ + µ)
w>0 B¯C( Z+µEn)
−1v0 = −w>0
[
Rβ0 En −
ξ
(γ + µ)
BC
]
( Z+µEn)
−1v0
Rβ1,P = −
β¯C(γ + ξµ)
(δ + µ)(γ + µ)µ
w>0 Ψ B¯C A¯v0 = −
β¯C(γ + ξµ)
(δ + µ)(γ + µ)µ
w>0 Ψρ
(
B¯C A¯
)
v0 = −Rβ0
1
(δ + µ)
w>0 Ψv0
Proof (Theorem 4.1). When computing the endemic equilibrium we let the equilibrium value of S be
equal to some (not yet known) value S∗. The respective equilibrium values of IAi and ICi are found as the
solution of the following system of 2n algebraic equations:
0 = ξβCS
∗ IA + βCS∗A IC − (γ + µ) IA
0 = γ IA − (u+ µ) IC,
(28)
From the first equation we get
I∗A =
βCS
∗
(γ + µ)− ξβCS∗ A I
∗
C.
Expressing I∗C from the second equation of (28) and substituting into the above equation we obtain the
expression for I∗A: [
((γ + µ)− ξβCS∗)(uT + µ)
βCγS∗
En − A
]
I∗A = Γ I
∗
A = 0, (29)
3Note that there is a typo in Eq. (10) in [5]. The correct expression is written next to Eq. (12) in op.cit.
19
that is I∗A belongs to the kernel of the matrix Γ =
((γ+µ)−ξβCS∗)(uT+µ)
βCγS∗
En − A. The matrix A is non-
singular, thus Γ has a non-trivial kernel only if the factor in front of En is equal to one of the eigenvalues of
A. The solution I∗A would be then equal (up to a positive factor) to the corresponding eigenvector. However,
as follows from the Perron-Frobenius theorem, the only positive eigenvector corresponds to its dominant
eigenvalue, which is equal to 1 for a stochastic matrix. Any other eigenvector would contain negative
components which contradict the assumption that all system’s states are non-negative. This implies that
the equilibrium value of S must satisfy the equation ((γ+µ)−ξβCS
∗)(uT+µ)
βCγS∗
− 1 = 0, whence we obtain
S∗ =
(γ + µ)(uT + µ)
ξβC(uT + µ) + βCγ
=
1
R0
. (30)
The equilibrium solution I∗A corresponds to the right dominant eigenvector of the column stochastic matrix
A. Since this eigenvector is defined up to the multiplication by a positive scalar, we can further specify it
using the following argument. Let iAΣ be the sum of all components of IA, i.e., iAΣ =
∑n
j=1 I
∗
Ai. Similarly,
we write iCΣ =
γ
(uT+µ)
iAΣ and subsequently, we get T
∗ = γu(uT+µ)µ iAΣ. Since all states sum to 1, we have
the following equation
iAΣ +
γ
(uT + µ)
iAΣ +
γu
(uT + µ)µ
iAΣ +
1
R0
= 1,
whence we get
iAΣ =
µ
(γ + µ)
(
1− 1
R0
)
, iCΣ =
γµ
(γ + µ)(uT + µ)
(
1− 1
R0
)
, T ∗ =
γu
(γ + µ)(uT + µ)
(
1− 1
R0
)
. (31)
Let v be the (normalized) dominant eigenvector of A such that
∑n
i=1 vi = 1. Multiplying the components
of v with the respective factors we obtain the expressions for IAi and ICi.
Finally, we observe that R0 < 1 implies that the respective components of the endemic equilibrium state
turn negative which implies that there is no admissible endemic equilibrium. This concludes the proof.
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